Decibel Therapeutics Taps Steven Holtzman as its New CEO

Decibel Therapeutics has tapped Steven Holtzman as its new president and chief executive officer.

Holtzman succeeds Kevin Starr, who will continue on as chairman of the company’s board of directors.

Holtzman, who previously served as executive vice president of corporate development at Biogen, has over 30 years of experience in the biotechnology industry. — Anisa Jibrell